Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.
Fuchs V, Sobarzo A, Msamra M, Kezerle Y, Linde L, Sevillya G, Anoze A, Refaely Y, Cohen AY, Melamed I, Azriel A, Shoukrun R, Raviv Y, Porgador A, Peled N, Roisman LC.
Fuchs V, et al. Among authors: azriel a.
Clin Transl Oncol. 2024 Mar 29. doi: 10.1007/s12094-024-03450-3. Online ahead of print.
Clin Transl Oncol. 2024.
PMID: 38553659